Frank Takkinen
Stock Analyst at Lake Street
(0.78)
# 3,832
Out of 4,906 analysts
57
Total ratings
24.56%
Success rate
-20.3%
Average return
Main Sectors:
Stocks Rated by Frank Takkinen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ANGO AngioDynamics | Initiates: Buy | $24 | $9.00 | +166.81% | 1 | Jul 16, 2025 | |
| BBNX Beta Bionics | Assumes: Buy | $30 | $14.30 | +109.79% | 1 | Jun 12, 2025 | |
| ELUT Elutia | Maintains: Buy | $10 → $8 | $2.18 | +266.97% | 3 | May 9, 2025 | |
| SGHT Sight Sciences | Maintains: Hold | $2.5 → $3 | $3.43 | -12.54% | 4 | May 9, 2025 | |
| NOTV Inotiv | Maintains: Buy | $6 → $5 | $1.73 | +189.02% | 7 | May 8, 2025 | |
| CVRX CVRx, Inc. | Maintains: Buy | $19 → $14 | $8.29 | +68.88% | 7 | Apr 8, 2025 | |
| LNSR LENSAR | Downgrades: Hold | $16 → $15 | $13.32 | +12.61% | 2 | Mar 24, 2025 | |
| HYPR Hyperfine | Initiates: Buy | $1.5 | $0.97 | +54.81% | 1 | Mar 24, 2025 | |
| AXGN Axogen | Initiates: Buy | $30 | $11.61 | +158.40% | 1 | Mar 17, 2025 | |
| CLBT Cellebrite DI | Maintains: Buy | $17 → $26 | $14.20 | +83.10% | 3 | Feb 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $30 | $10.98 | +173.22% | 4 | Jan 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 → $5 | $3.46 | +44.51% | 2 | Jan 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $20 | $3.01 | +565.56% | 1 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $2.52 | +98.65% | 1 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $8 | $1.98 | +304.04% | 2 | Aug 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $28 → $30 | $30.64 | -2.09% | 2 | Jul 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $3.18 | +277.36% | 1 | Jun 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 → $6 | $1.61 | +272.67% | 2 | Apr 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 → $4 | $2.23 | +79.37% | 2 | Mar 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $12 | $9.36 | +28.21% | 2 | Dec 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $305 → $350 | $125.14 | +179.69% | 1 | Aug 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 → $9 | $2.22 | +305.41% | 3 | Jun 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $16 | $1.51 | +959.60% | 2 | May 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $31 → $9.23 | $0.60 | +1,446.06% | 2 | Jan 18, 2023 |
AngioDynamics
Jul 16, 2025
Initiates: Buy
Price Target: $24
Current: $9.00
Upside: +166.81%
Beta Bionics
Jun 12, 2025
Assumes: Buy
Price Target: $30
Current: $14.30
Upside: +109.79%
Elutia
May 9, 2025
Maintains: Buy
Price Target: $10 → $8
Current: $2.18
Upside: +266.97%
Sight Sciences
May 9, 2025
Maintains: Hold
Price Target: $2.5 → $3
Current: $3.43
Upside: -12.54%
Inotiv
May 8, 2025
Maintains: Buy
Price Target: $6 → $5
Current: $1.73
Upside: +189.02%
CVRx, Inc.
Apr 8, 2025
Maintains: Buy
Price Target: $19 → $14
Current: $8.29
Upside: +68.88%
LENSAR
Mar 24, 2025
Downgrades: Hold
Price Target: $16 → $15
Current: $13.32
Upside: +12.61%
Hyperfine
Mar 24, 2025
Initiates: Buy
Price Target: $1.5
Current: $0.97
Upside: +54.81%
Axogen
Mar 17, 2025
Initiates: Buy
Price Target: $30
Current: $11.61
Upside: +158.40%
Cellebrite DI
Feb 14, 2025
Maintains: Buy
Price Target: $17 → $26
Current: $14.20
Upside: +83.10%
Jan 21, 2025
Maintains: Buy
Price Target: $17 → $30
Current: $10.98
Upside: +173.22%
Jan 14, 2025
Maintains: Buy
Price Target: $4 → $5
Current: $3.46
Upside: +44.51%
Jan 8, 2025
Initiates: Buy
Price Target: $20
Current: $3.01
Upside: +565.56%
Dec 11, 2024
Initiates: Buy
Price Target: $5
Current: $2.52
Upside: +98.65%
Aug 13, 2024
Maintains: Buy
Price Target: $14 → $8
Current: $1.98
Upside: +304.04%
Jul 2, 2024
Maintains: Buy
Price Target: $28 → $30
Current: $30.64
Upside: -2.09%
Jun 4, 2024
Initiates: Buy
Price Target: $12
Current: $3.18
Upside: +277.36%
Apr 3, 2024
Maintains: Buy
Price Target: $3 → $6
Current: $1.61
Upside: +272.67%
Mar 5, 2024
Maintains: Buy
Price Target: $3 → $4
Current: $2.23
Upside: +79.37%
Dec 27, 2023
Reiterates: Buy
Price Target: $12
Current: $9.36
Upside: +28.21%
Aug 2, 2023
Maintains: Buy
Price Target: $305 → $350
Current: $125.14
Upside: +179.69%
Jun 15, 2023
Maintains: Buy
Price Target: $6 → $9
Current: $2.22
Upside: +305.41%
May 18, 2023
Maintains: Buy
Price Target: $14 → $16
Current: $1.51
Upside: +959.60%
Jan 18, 2023
Maintains: Buy
Price Target: $31 → $9.23
Current: $0.60
Upside: +1,446.06%